Skip to main content
. 2025 Jun 4;18(6):841. doi: 10.3390/ph18060841
BCR Biochemical recurrence
CT Computed tomography
EMA European Medicines Agency
FDA US Food and Drug Administration
mCRPC Metastatic castration-resistant prostate cancer
MRI Magnetic resonance imaging
NIR Near-infrared
PCa Prostate cancer
PET Positron emission tomography
pCLE Probe-based confocal laser endomicroscopy
PSM Positive surgical margin
PSMA Prostate-specific membrane antigen